{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-052152","form_type":"8-K","ticker":"SRTA","cik":"0001779128","company_name":"Strata Critical Medical, Inc.","filed_at":"2026-08-04T11:13:54+00:00","discovered_at":"2026-08-04T11:15:02.363187+00:00","generated_at":"2026-08-04T11:15:14.395778+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Strata Critical Medical Q2 revenue $72.5M (+60.7% YoY); net loss $(10.5)M","bullets":["Revenue $72.5M, up 60.7% YoY; Clinical segment contributed $24.3M vs. zero in prior year.","Net loss from continuing ops $(10.5)M (14.5% of revenue) vs. $(3.4)M loss a year ago.","Adjusted EBITDA $7.9M (10.9% margin); operating cash flow $5.7M, free cash flow $2.9M.","Completed bolt-on acquisitions of Louisville Perfusion, Heart/Lung Transplant Recovery, Ohio Valley Perfusion in Q2.","Signed agreement to take over Statline's Transplant Center Organ Placement customer relationships over next year."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-052152","json":"https://secwatch.observer/filing/0001628280-26-052152.json","markdown":"https://secwatch.observer/filing/0001628280-26-052152.md","text":"https://secwatch.observer/filing/0001628280-26-052152.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/0001628280-26-052152-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/srta-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T11:15:14.395778+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}